1. Wang, Yan, Dan, Liangying, Li, Qianqian, Lin, Yong, Xiang, Tingxiu. 2019. ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer. In Clinical epigenetics, 11, 184. doi:10.1186/s13148-019-0785-z. https://pubmed.ncbi.nlm.nih.gov/31801619/
2. Shi, Lei, Shen, Yuan. 2022. Silencing of ciliary protein ZMYND10 affects amitotic macronucleus division in Paramecium tetraurelia. In European journal of protistology, 82, 125863. doi:10.1016/j.ejop.2021.125863. https://pubmed.ncbi.nlm.nih.gov/35065333/
3. Zariwala, Maimoona A, Gee, Heon Yung, Kurkowiak, Małgorzata, Knowles, Michael R, Hildebrandt, Friedhelm. 2013. ZMYND10 is mutated in primary ciliary dyskinesia and interacts with LRRC6. In American journal of human genetics, 93, 336-45. doi:10.1016/j.ajhg.2013.06.007. https://pubmed.ncbi.nlm.nih.gov/23891469/
4. Kurkowiak, Małgorzata, Ziętkiewicz, Ewa, Greber, Agnieszka, Pogorzelski, Andrzej, Witt, Michał. 2016. ZMYND10--Mutation Analysis in Slavic Patients with Primary Ciliary Dyskinesia. In PloS one, 11, e0148067. doi:10.1371/journal.pone.0148067. https://pubmed.ncbi.nlm.nih.gov/26824761/
5. Shi, Lei, Shen, Xiangyu, Chi, Yuhao, Shen, Yuan. 2020. Primary ciliary dyskinesia relative protein ZMYND10 is involved in regulating ciliary function and intraflagellar transport in Paramecium tetraurelia. In European journal of protistology, 77, 125756. doi:10.1016/j.ejop.2020.125756. https://pubmed.ncbi.nlm.nih.gov/33279757/